Literature DB >> 17325818

Glucose hypermetabolism in the thalamus of patients with essential blepharospasm.

Yukihisa Suzuki1, Shoichi Mizoguchi, Motohiro Kiyosawa, Manabu Mochizuki, Kiichi Ishiwata, Masato Wakakura, Kenji Ishii.   

Abstract

Essential blepharospasm (EB) is classified as a form of focal dystonia characterized by involuntary spasms of the musculature of the upper face. The basic neurological process causing EB is not known. The purpose of this study was to investigate cerebral glucose metabolism in patients with EB whose symptoms were suppressed by an injection of botulinum-A toxin. Earlier studies were confounded by sensory feedback activities derived from dystonic symptom itself. Cerebral glucose metabolism was examined by positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) in 25 patients (8 men and 17 women; age 52.6 +/- 10.1 years) with EB. The patients were awake but with the spasms suppressed by an injection of botulinum-A toxin. Thirty-eight normal volunteers (14 men and 24 women; age 58.2 +/- 7.3 years) were examined as controls. The difference between the two groups was examined by statistical parametric mapping (SPM99). A significant increase in the glucose metabolism was detected in the thalamus and pons in the EB patients. Hyperactivity in the thalamus may be a key pathophysiological change common to EB and other types of focal dystonia. The activity of the striatum and cerebellum are likely to be sensory dependent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325818     DOI: 10.1007/s00415-006-0468-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Impaired brain GABA in focal dystonia.

Authors:  Lucien M Levy; Mark Hallett
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

2.  Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.

Authors:  G-Y R Hsiung; S K Das; R Ranawaya; A-L Lafontaine; O Suchowersky
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

3.  Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis.

Authors:  G Galardi; D Perani; F Grassi; S Bressi; S Amadio; M Antoni; G C Comi; N Canal; F Fazio
Journal:  Acta Neurol Scand       Date:  1996-09       Impact factor: 3.209

4.  Abnormal cortical responses in patients with writer's cramp.

Authors:  L W Tempel; J S Perlmutter
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

5.  Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study.

Authors:  A O Ceballos-Baumann; G Sheean; R E Passingham; C D Marsden; D J Brooks
Journal:  Brain       Date:  1997-04       Impact factor: 13.501

6.  Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia.

Authors:  J S Perlmutter; M K Stambuk; J Markham; K J Black; L McGee-Minnich; J Jankovic; S M Moerlein
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

Review 7.  Secondary cervical dystonia associated with structural lesions of the central nervous system.

Authors:  Mark S LeDoux; Kimberly A Brady
Journal:  Mov Disord       Date:  2003-01       Impact factor: 10.338

8.  Striatal activation during blepharospasm revealed by fMRI.

Authors:  Kerstin E Schmidt; David E J Linden; Rainer Goebel; Friedhelm E Zanella; H Lanfermann; Alina A Zubcov
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

9.  Positron emission tomography in patients with benign essential blepharospasm.

Authors:  B Esmaeli-Gutstein; C Nahmias; M Thompson; M Kazdan; J Harvey
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1999-01       Impact factor: 1.746

10.  Blepharospasm in association with a lower pontine lesion.

Authors:  M Aramideh; B W Ongerboer de Visser; G Holstege; C B Majoie; J D Speelman
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

View more
  15 in total

Review 1.  Update on blepharospasm: report from the BEBRF International Workshop.

Authors:  Mark Hallett; Craig Evinger; Joseph Jankovic; Mark Stacy
Journal:  Neurology       Date:  2008-10-14       Impact factor: 9.910

Review 2.  Secondary blepharospasm associated with structural lesions of the brain.

Authors:  M A Khooshnoodi; S A Factor; H A Jinnah
Journal:  J Neurol Sci       Date:  2013-06-06       Impact factor: 3.181

Review 3.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

Review 4.  Neuroimaging Applications in Dystonia.

Authors:  Kristina Simonyan
Journal:  Int Rev Neurobiol       Date:  2018-10-23       Impact factor: 3.230

5.  Diffusion tensor imaging in blepharospasm and blepharospasm-oromandibular dystonia.

Authors:  Jing Yang; ChunYan Luo; Wei Song; XiaoYan Guo; Bi Zhao; XuePing Chen; XiaoQi Huang; QiYong Gong; Hui-Fang Shang
Journal:  J Neurol       Date:  2014-05-03       Impact factor: 4.849

6.  Gray Matter Structural and Functional Alterations in Idiopathic Blepharospasm: A Multimodal Meta-Analysis of VBM and Functional Neuroimaging Studies.

Authors:  Meng Zhang; Xiang Huang; Boyi Li; Huifang Shang; Jing Yang
Journal:  Front Neurol       Date:  2022-06-06       Impact factor: 4.086

7.  Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.

Authors:  Yoshihiko Isshiki; Hiroto Ishikawa; Osamu Mimura
Journal:  Jpn J Ophthalmol       Date:  2016-08-08       Impact factor: 2.447

Review 8.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

9.  Positive Correlation between Severity of Blepharospasm and Thalamic Glucose Metabolism.

Authors:  Hideki Murai; Yukihisa Suzuki; Motohiro Kiyosawa; Masato Wakakura; Manabu Mochizuki; Kiichi Ishiwata; Kenji Ishii
Journal:  Case Rep Ophthalmol       Date:  2011-02-05

Review 10.  Blepharospasm: Update on Epidemiology, Clinical Aspects, and Pathophysiology.

Authors:  Josep Valls-Sole; Giovanni Defazio
Journal:  Front Neurol       Date:  2016-03-31       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.